β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells

Molecular Cancer Therapeutics

Volumn 7, Issue 1, 2008, Pages 181-190

  Janakiram, Naveena B ^a   Cooma, Indranie ^a   Mohammed, Altaf ^a   Steele, Vernon E ^b   Rao, Chinthalapally V ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABERRANT CRYPT FOCI; AZOXYMETHANE; BETA LONONE; HERBACEOUS AGENT; MARKER; MESSENGER RNA; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; COLON CANCER; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; AZOXYMETHANE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR STRUCTURE; NORISOPRENOIDS; RATS; RATS, INBRED F344; RETINOID X RECEPTOR ALPHA; RNA, MESSENGER;

EID: 38349188175     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-0529     Document Type: Article

References (49)

1. Elson CE, Yu SG. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J Nutr 1994;124:607-14.
2. Block G, Patterson B, Subar AA. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992;18:1-29.
3. Michaud DSP, Taylor PR, Virtanen M, Virtamo J, Albanes D. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br J cancer 2002;87:960-65.
4. Ito LS, Inuone M, Tajima K, et al. Dietary factors and risk of gastric cancer among Japanese women a comparison between the differentiated and non-differentiated subtypes. Ann Epidemiol 2003;13:24-31.
5. Willet WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695-98.
6. Elson CE. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J Nutr 1995;125:1666-72s.
7. Bach TJ. Some new aspects of isoprenoids biosynthesis in plants a review. Lipids 1995;30:191-202.
8. Steinmetz KA, Potter JD. Vegetables, fruits, and cancer prevention: a review. J Am Diet Assoc 1996;96:1027-39.
9. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007;55:207-16.
10. Moise AR, Noy N, Palczewski K, Blaner WS. Delivery of retinoid-based therapies to target tissues. Biochemistry 2007;46:4449-58.
11. Olefsky JM. Nuclear receptor minireview series. J Biol Chem 2001;276:36863-64.
12. Mo H, Elson CE. Apoptosis and cell cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr 1999;129:804-13.
13. Yu SG, Anderson PJ, Elson CE. Efficacy of β-ionone in the chemoprevention of rat mammary carcinogenesis. J Agric Food Chem 1995;43:2144-7.
14. He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 1997;127:668-74.
15. Riebeling C, Forsea AM, Raisova M, Orfanos CE, Geilen CC. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro. Br J Cancer 2002;87:366-71.
16. Tatman D, Mo H. Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett 2002;175:129-39.
17. Johnson MD, Woodard A, Okediji EJ, Toms SA, Allen GS. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. J Neurooncol 2002;56:133-42.
18. Jia-Ren L, Bing-Qing C, Bao-Fe ng Y,et al. Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J Gastroenterol 2004;10:348-51.
19. Elson CE, Peffley DM, Hentosh P, Mo H. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proc Soc Exp Biol Med 1999;221:294-311.
20. Landegren U. Measurement of cell numbers by means of endogenous enzyme hexose aminidase: applications to detection of lymphokines and cell surface antigens. J Immunol Methods 1984;67:379-88.
21. waf1/cip1 in colon cancer cells. Mol Cancer Ther 2006;5:1459-66.
22. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995;93:55-71.
23. Elizabeth TJ, Mark RH, Maria EM. Vitamin D activity and colorectal neoplasia: a pathway approach to epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2005;14:2061-3.
24. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res 1992;52:2024-9s.
25. Rogers AE, Zeisel S, Groopman J. Diet and carcinogenesis. Carcinogenesis 1993;14:2205-17.
26. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
27. Wattenberg LW. Inhibition of carcinogenesis by nonnutrient constituents of the diet. In: Waldron KW, Johnson IT, Fenwick GR, editors. Food and cancer prevention: chemical and biological aspects. Cambridge (UK): The Royal Society of Chemistry; 1993. p. 12-23.
28. Lyn P. β-Carotene: the controversy continues. Altern Med Rev 2000;5:530-45.
29. Hansen LA, Sigman CC, Andreola F, et al. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;2:1271-9.
30. Desreumaux P, Dubuquoy L, Nutten S, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/ peroxisome proliferator-activated receptor γ (PPARγ) heterodimer. A basis for new therapeutic strategies. J Exp Med 2001;193:827-38.
31. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992;68:397-406.
32. Levin AA, Sturzenbecker LJ, Kazmer S, et al. 9-cis Retinoic acid stereoisomer binds and activates the nuclear receptor RXR. Nature 1992;355:359-61.
33. Wang XD, Russell RM. Procarcinogenic and anticarcinogenic effects of β-carotene. Nutr Rev 1999;57:263-72.
34. Eiserich JP, Vander VA, Handelman GJ, et al. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995;612:1490-500S.
35. Obermuller-Jevic UC, Francz PI, Frank J, Flaccus A, Biesalski HK. Enhancement of UVA induction of heme oxygenase-1 expression by β-carotene in human skin fibroblasts. FEBS Lett 1999;460:212-6.
36. Palozza P, Serini S, Torsello A, et al. β-Carotene regulates NF-κB DNA-binding activity by a redox mechanisms in human leukemia and colon adenocarcinoma cells. J Nutr 2003;133:381-8.
37. Paolini M, Antelli A, Pozzetti L, et al. Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in β-carotene supplemented rats. Carcinogenesis 2001;22:1483-95.
38. α-Tocopherol β-Carotene Cancer Prevention Study Group. The effects of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
39. Bertram JS. Carotenoids and gene regulation. Nutr Rev 1999;57:182-91.
40. Raju J, Malisetty VS, Cooma I, et al. Low doses of β-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence. Int J Cancer 2005;113:798-802.
41. Espindola R, Mazzantini RP, Ong TP, Conti A, Heidor R, Moreno FS. Geranylgeraniol and β-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-κB activation. Carcinogenesis 2005;26:1091-9.
42. Rao CV, Simi B, Reddy BS. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase,tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 1993;14:2219-25.
43. Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993;53:4182-8.
44. Jayadev R, Jagan MRP, Malisetty VS, Rao CV. Colon cancer preventive effects of Trigonella foenum graecum (fenugreek) seed and its constituent diosgenin in vivo and in vitro. Cancer Epidemiol Biomarkers Prev 2004;13:1392-8.
45. Xu XC, Wong WYL, Goldberg L, et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 2001;61:4306-10.
46. Darwiche B, Celli G, Tennenbaum T, Glick AB, Yuspa SH, DeLuca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res 1995;55:2774-82.
47. Jiang S-Y. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization. Br J Cancer 1999;80:206-14.
48. Sivakumar K, Maripat C, Sharon YJ, et al. The R-enantiomer of the nonsteroidal anti-inflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Proc Natl Acad Sci 2005;102:2525-30.
49. Mao GE, Reuter VE, Cordon-Cardo C,et al. Decreased retinoid X receptor-α protein expression in basal cells occurs in the early stage of human prostate cancer development. Cancer Epidemiol Biomarkers Prev 2004;13:383-90.